跳至主要内容
临床试验/NCT04317404
NCT04317404已完成不适用

Identifying Variables Associated With Steroid-Induced Hyperglycemia Following Intra-articular Knee Injections Among Diabetic Patients

University of Texas Southwestern Medical Center1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2020年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
11
试验地点
1
主要终点
Post-injection glucose levels

研究概览

简要总结

A prospective, observational study assessing the relationship between HbA1c level and the post-injection blood glucose signature. Participants will be non-diabetic, pre-diabetic, non-insulin dependent and insulin dependent type 2 diabetic patients who will be receiving a knee steroid injection. All of them will be consented a week prior to the injection, when the CGM sensor will be applied to the back of the upper arm. This will be removed a week after the injection. KOOS survey as well as VAS will be administered. Adverse events (e.g., change in medication or hospitalization) will be monitored throughout the study.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients at the Parkland Outpatient Clinic
  • Indication for unilateral knee joint steroid injection for the treatment of knee joint osteoarthritis

排除标准

  • Less than 18 years old
  • HbA1c > 12.0%
  • steroid exposure in the 3 months prior to Visit 1
  • 3 or more steroid injections in the preceding 12 months
  • known contraindication to steroid injection (adverse reaction or allergy, active infection, INR > 3.0)
  • lack of improvement with prior knee steroid injection
  • change in diabetic medication regimen in the last 1 month
  • significant change in diet within the last 1 month
  • current use of aspirin
  • allergy to adhesive
  • planned MRI, XR, or CT during the 2-week study period

研究组 & 干预措施

Diabetic with Knee Osteoarthritis

HbA1c between 6.5% - 12.0% in the 3 months prior to Visit 1

干预措施: 40 mg Triamcinolone acetonide (Drug)

Pre-diabetic with Knee Osteoarthritis

HbA1c between 5.6% - 6.4% in the 3 months prior to Visit 1

干预措施: 40 mg Triamcinolone acetonide (Drug)

Non-diabetic with Knee Osteoarthritis

HbA1c < 5.6% in the 3 months prior to Visit 1

干预措施: 40 mg Triamcinolone acetonide (Drug)

结局指标

主要结局

Post-injection glucose levels

时间窗: 1 week

Blood glucose levels after injection of steroid to the knee

次要结局

  • KOOS Knee survey(2 weeks)
  • Post-injection adverse events(1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Reed Williams

Assistant Professor

University of Texas Southwestern Medical Center

研究点 (1)

Loading locations...

相似试验